Ray, Arghya
Song, Yan
Du, Ting
Tai, Yu-Tzu
Chauhan, Dharminder
Anderson, Kenneth C.
Article History
Received: 27 February 2019
Revised: 9 June 2019
Accepted: 9 July 2019
First Online: 28 August 2019
Compliance with ethical standards
:
: KCA is on Advisory board of Celgene, Millenium-Takeda, Gilead, Janssen, and Bristol Myers Squibb, and is a Scientific Founder of Oncopep and C4 Therapeutics. DC is a consultant to Stemline Therapeutic, Inc., and equity owner in C4 Therapeutics. The remaining authors declare no conflict of interest.